Explore more publications!

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on October 13, 2025

Marco Island Police Department Accepts Anti Choking Devices  Donated by Rosario S. Cassata of The Cassata Foundation
iRemedy CEO Tony Paquin Testifies Before U.S. Senate Committee on Aging
Healthy Workforce Institute Announces #1 Amazon Best Seller Enough! Eradicate Bullying & Incivility in Healthcare 2nd Ed
From Awareness to Action: Why Lymphedema Education Belongs in Every Breast Cancer Program
Zuri Plastic Surgery Expands Its Mission of Holistic Care with Hydrology Wellness
The Lodge Health & Rehabilitation Earns 2025 Regional Best of Florida Award
AAFA Bill to Require Allergen Labeling in California Restaurants Becomes Law
LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME’s “Best Inventions of 2025”
Polyols Market worth $21.59 billion by 2030, at a CAGR of 5.1%, says MarketsandMarkets™
ImpactLife donor receives induction into National Blood Donation Hall of Fame
Geron Corporation Announces Executive Leadership Transitions and Appointments
MAIA Biotechnology Announces $736,600 Private Placement
Tilray Medical Announces Expansion Plans in Panama, Strengthening Global Cannabis Leadership and Accelerating International Growth
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Zentalis Pharmaceuticals Announces Four Azenosertib Posters Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Pyxis Oncology to Present Translational Data and Key Biology Findings Elucidating the Mechanism of Action of MICVO at Upcoming Medical Meetings
iMDx Welcomes New VP Marketing to Prepare for Commercial Transplant Assay Launch
BBOT Announces Poster Presentations at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
PMV Pharmaceuticals to Present Rezatapopt Pivotal Phase 2 Initial Analysis and Natural History Study Results at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions